-2 Market - Top Companies and Manufacturers

Companies Dominating the Congenital Anomalies Treatment Landscape

Johnson & Johnson Services, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
GlaxoSmithKline plc.
Regeneron Pharmaceuticals, Inc.
BioMarin Pharmaceutical Inc.
Amgen Inc.
Alexion Pharmaceuticals, Inc.
Merck KGaA
Novartis International AG
Ipsen Pharma
Fresenius Kabi USA

Browse Key Market Insights with Data Illustration:

Congenital Anomalies Treatment Market Size & Share, Forecast Report 2037

In the News

December 20, 2021: Merck KGaA announced the acquisition of Chord Therapeutics to expand its neuro-inflammatory pipeline, to develop cladribine drug.
December 01, 2020: Fresenius Kabi launched a new Icatibant injection to treat acute attacks of hereditary angioedema in adults. Icatibant injection is an FDA-approved, cost-effective and quick-relief alternative to treat attacks of hereditary angioedema (HAE).

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of congenital anomalies treatment is assessed at USD 172.27 million.

Congenital Anomalies Treatment Market size was over USD 165.79 million in 2024 and is projected to reach USD 297.49 million by 2037, witnessing around 4.6% CAGR during the forecast period i.e., between 2025-2037.

Asia Pacific industry is predicted to account for largest revenue share by 2037, on the back of advancements in the healthcare sector, and rising healthcare expenditure across the region.

The major players in the market are GlaxoSmithKline plc, Regeneron Pharmaceuticals, Inc., BioMarin Pharmaceutical Inc., Amgen Inc., Alexion Pharmaceuticals, Inc., Merck KGaA, Novartis International AG, Ipsen Pharma, Fresenius Kabi USA, and others.

-2 Market - Top Companies and Manufacturers

Companies Dominating the Congenital Anomalies Treatment Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What is the size of the congenital anomalies treatment market?

Why is the congenital anomalies treatment sector gaining traction in near future?

Which region held the largest congenital anomalies treatment industry share?

Who are the major congenital anomalies treatment players?